Live from the NIH registry
Studies recruiting near Macon right now
Top 25 of 74 recruiting studies, sorted by proximity — each links to its official registry page
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Children's Oncology Group
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Macon, Georgia (4.5 mi)
· Sponsor: ViiV Healthcare
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 1033 — Macon, Georgia (4.5 mi)
· Sponsor: Anthos Therapeutics, Inc.
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (4.5 mi)
· Sponsor: vTv Therapeutics
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Phase 3
Interventional 1,200 participants sought
Gastroenterology Associates of Central Georgia ( Site 5048) — Macon, Georgia (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Central Georgia Cancer Care - Macon — Macon, Georgia (4.5 mi)
· Sponsor: Mirati Therapeutics Inc.
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 224 participants sought
Novartis Investigative Site — Macon, Georgia (4.5 mi)
· Sponsor: Novartis Pharmaceuticals
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Central Georgia Cancer Care — Macon, Georgia (4.5 mi)
· Sponsor: Summit Therapeutics
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
The Jones Center Clinical Research — Macon, Georgia (4.5 mi)
· Sponsor: Amgen
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Left-sided Colorectal Cancer
Phase 3
Interventional 960 participants sought
Central Georgia Cancer Care - Warner Robins Office — Warner Robins, Georgia (13.8 mi)
· Sponsor: Genmab
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Lung Cancer Screening, Lung Neoplasms
N/A
Interventional 80 participants sought
Pavilion Family Medicine Center — Warner Robins, Georgia (13.8 mi)
· Sponsor: University of California, Irvine
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Phase 2, Phase 3
Interventional 570 participants sought
Mercer university, Department of internal medicine-Clinical Research ( Site 1512) — Macon, Georgia (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Macon, Georgia (4.5 mi)
· Sponsor: Alkermes, Inc.
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Children's Oncology Group
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Sleep Practitioners, LLC — Macon, Georgia (4.5 mi)
· Sponsor: Eisai Inc.
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Gastroenterology Associates of Central GA — Macon, Georgia (4.5 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 74 participants sought
Research Site — Macon, Georgia (4.5 mi)
· Sponsor: Maze Therapeutics
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
HIV-1-infection
Phase 2
Interventional 175 participants sought
Mercer University, Department of Internal Medicine — Macon, Georgia (4.5 mi)
· Sponsor: Gilead Sciences
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma
Phase 3
Interventional 205 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Children's Oncology Group
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (4.5 mi)
· Sponsor: Hoffmann-La Roche
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Children's Oncology Group
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Phase 3
Interventional 330 participants sought
Central Georgia Cancer Care PC — Macon, Georgia (4.5 mi)
· Sponsor: Amgen
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Macon, Georgia (4.5 mi)
· Sponsor: Alnylam Pharmaceuticals
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Osteomyelitis Tibia, Tibial Fractures
Phase 4
Interventional 242 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Wake Forest University Health Sciences
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Randomize Now-Burton Medical — Macon, Georgia (4.5 mi)
· Sponsor: Cleerly, Inc.